OpenFilings
Akero Therapeutics, Inc.
Form
8-K
Report Period
2024-03-04
Date Filed
2024-03-04
Time Filed
07:55:33
Document Analysis
Natural Language Processing
Recognized Type
Unidentified
Defined Term Format
Underlined
Italicized
Bold
Exhibits
8-K
EX-99.1
EX-99.2
Filing on SEC Edgar